2-{[(4-methylphenyl)methyl]sulfanyl}-4-[(3-methylphenyl)sulfanyl]-5,6,7,8-tetrahydroquinazoline

Catalog No. :
ACWXAK030
CAS No. :
343374-10-7
Molecular Formula :
C23H24N2S2
Molecular Weight :
392.59

IUPAC Name:2-((4-methylbenzyl)thio)-4-(m-tolylthio)-5,6,7,8-tetrahydroquinazoline

2-{[(4-methylphenyl)methyl]sulfanyl}-4-[(3-methylphenyl)sulfanyl]-5,6,7,8-tetrahydroquinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[(4-methylphenyl)methyl]sulfanyl}-4-[(3-methylphenyl)sulfanyl]-5,6,7,8-tetrahydroquinazoline
IUPAC Name2-((4-methylbenzyl)thio)-4-(m-tolylthio)-5,6,7,8-tetrahydroquinazoline
Molecular FormulaC23H24N2S2
Molecular Weight392.59
SMILESCC1=CC(SC2=C3CCCCC3=NC(SCC4=CC=C(C)C=C4)=N2)=CC=C1
InChI KeyWCXRLOHESDFXND-UHFFFAOYSA-N
Synonym2-[(4-METHYLBENZYL)SULFANYL]-4-[(3-METHYLPHENYL)SULFANYL]-5,6,7,8-TETRAHYDROQUINAZOLINE;4-METHYLBENZYL 4-[(3-METHYLPHENYL)SULFANYL]-5,6,7,8-TETRAHYDRO-2-QUINAZOLINYL SULFIDE;2-{[(4-methylphenyl)methyl]sulfanyl}-4-[(3-methylphenyl)sulfanyl]-5,6,7,8-tetrahydroquinazoline;Quinazoline, 5,6,7,8-tetrahydro-2-[[(4-methylphenyl)methyl]thio]-4-[(3-methylphenyl)thio]-
CAS No.343374-10-7

Synthetic Route by SureRoute

1. ACWXAK030 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWXAK030 route product structure diagram
    ACWXAK030343374-10-7
Inquiry

2. ACWXAK030 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWXAK030 route product structure diagram
    ACWXAK030343374-10-7
Inquiry

Comments (0)